These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 808393)

  • 1. Advances in the understanding of the anticoagulant function of heparin.
    Rosenberg JS; Rosenberg RD
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):66-78. PubMed ID: 808393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 4. [State of the blood coagulation and tissue blood coagulation factors in hypokinesia in heparinized rabbits].
    Sviridkina LP; Inchina VI; Grinevskaia IuI
    Kosm Biol Aviakosm Med; 1979; 13(4):87-9. PubMed ID: 459411
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulable states: new knowledge about old problems.
    Moake JL
    Hosp Pract (Off Ed); 1991 Mar; 26(3A):31-42. PubMed ID: 1826007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 10. [Natural and therapeutic regulation on blood coagulation].
    Fukutake K
    Nihon Rinsho; 1989 Apr; 47(4):732-8. PubMed ID: 2746883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA; Pastorova VE; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology of blood coagulation and fibrinolysis: biochemistry].
    Preissner KT
    Hamostaseologie; 2008 Dec; 28(5):259-71. PubMed ID: 19132158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heparin].
    Roszkowska W; Worowski K
    Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 18. [New data on the nature and function of the anticoagulation system].
    Kudriashov BA
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):3-12. PubMed ID: 4156880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of inhibition of blood coagulation (author's transl)].
    Kurachi K
    Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.